At a glance
- Originator Bayer Schering Pharma
- Class Cardiotonics; Vasodilators
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure
Most Recent Events
- 15 Jun 2004 Discontinued - Preclinical for Heart failure in Germany (unspecified route)